From: A European inventory of common electronic health record data elements for clinical trial feasibility
Cardiovascular | Diabetes | Inflammatory | Oncology | Neurology | |
---|---|---|---|---|---|
AMGEN | 1 | ||||
AstraZeneca | 1 | ||||
Bayer Health Care | 2 | ||||
GlaxoSmithKline | 3 | ||||
Johnson & Johnson | 1 | 1 | |||
MERCK KGaA | 2 | ||||
Novartis Pharma AG | 1 | 1 | 1 | ||
F. Hoffmann-La Roche Ltd. | 1 | ||||
Sanofi-Aventis | 2 |